{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T04:05:12Z","timestamp":1749787512153,"version":"3.41.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>This study aimed to investigate the differential distribution of the genotypes of the TM6SF2 rs58542926 polymorphism in circulating tumor DNA (ctDNA) versus peripheral blood cells (PBMC) and its association with the development of hepatocellular carcinoma (HCC) in patients infected with the hepatitis C virus (HCV) in Egypt. A total of 147 HCC patients were enrolled in the study, and their genomic and ctDNA were analyzed for the TM6SF2 rs58542926 genotype. The CC genotype was identified as the most common among patients with HCC in Egypt, while the CT genotype was associated with higher serum direct bilirubin, total leucocyte count, and hemoglobin levels than those with the CC genotype. Circulating samples from patients with the CT genotype had significantly higher serum direct bilirubin, ALT, and prothrombin time than those with the CC genotype, as well as a significantly higher percentage of smokers, alcohol intake, and HCV PCR-positive patients. Our findings suggest that lifestyle factors such as smoking and alcohol intake may contribute to the development of HCC in patients with the CT genotype. Both genomic and ctDNA for the TM6SF2 rs58542926 genotype complemented and correlated with parameters of chronic liver disease and underlying risk factors for HCC. Circulating DNA for gene polymorphism provided additional real-time information and more value in correlation with the worsening of liver condition and the presence of HCC risk factors.<\/jats:p>","DOI":"10.1007\/s12672-025-02812-9","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T10:05:25Z","timestamp":1749722725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of differential detection of TM6SF2 rs58542926 mutation in circulating tumor DNA versus peripheral blood cells on hepatocellular carcinoma patients"],"prefix":"10.1007","volume":"16","author":[{"given":"Samar Samir","family":"Youssef","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman Abd El Razek","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Hassany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya Shaaban Ragheb","family":"Shaaban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman Elsayed Abass","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer","family":"Elbaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"issue":"11","key":"2812_CR1","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1080\/17474124.2021.1991792","volume":"15","author":"P Konyn","year":"2021","unstructured":"Konyn P, Ahmed A, Kim D. Current epidemiology in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2021;15(11):1295\u2013307.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"4","key":"2812_CR2","doi-asserted-by":"publisher","first-page":"402","DOI":"10.21608\/aeji.2022.169214.1261","volume":"12","author":"IM Elkenawy","year":"2022","unstructured":"Elkenawy IM, El-Bendary M, EL-Gilany A-H, Shabana W. Characteristics of hepatocellular carcinoma in Egyptian patients: a Single Center Pilot Study. Afro-Egypt J Infect Endemic Dis. 2022;12(4):402\u20139.","journal-title":"Afro-Egypt J Infect Endemic Dis."},{"key":"2812_CR3","doi-asserted-by":"crossref","unstructured":"Rashed WM. Current hcc clinical and research in egypt. Liver Cancer in the Middle East. 202; Cham: Springer. pp. 313\u201321.","DOI":"10.1007\/978-3-030-78737-0_19"},{"key":"2812_CR4","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2147\/JHC.S462168","volume":"11","author":"Y-K Li","year":"2024","unstructured":"Li Y-K, Wu S, Wu Y-S, Zhang W-H, Wang Y, Li Y-H, et al. Portal venous and hepatic arterial coefficients predict post-hepatectomy overall and recurrence-free survival in patients with hepatocellular carcinoma: a retrospective study. J Hepatocell Carcinoma. 2024;11:1389\u2013402.","journal-title":"J Hepatocell Carcinoma."},{"key":"2812_CR5","doi-asserted-by":"publisher","first-page":"1519999","DOI":"10.3389\/fimmu.2024.1519999","volume":"15","author":"J Li","year":"2025","unstructured":"Li J, Liang Y-B, Wang Q-B, Li Y-K, Chen X-M, Luo W-L, et al. Tumor-associated lymphatic vessel density is a postoperative prognostic biomarker of hepatobiliary cancers: a systematic review and meta-analysis. Front Immunol. 2025;15:1519999.","journal-title":"Front Immunol"},{"issue":"3","key":"2812_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jhep.2012.02.035","volume":"57","author":"P Nahon","year":"2012","unstructured":"Nahon P, Zucman-Rossi J. Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis. J Hepatol. 2012;57(3):663\u201374.","journal-title":"J Hepatol"},{"issue":"4","key":"2812_CR7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ng.2901","volume":"46","author":"J Kozlitina","year":"2014","unstructured":"Kozlitina J, Smagris E, Stender S, Nordestgaard BG, Zhou HH, Tybj\u00e6rg-Hansen A, et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2014;46(4):352\u20136.","journal-title":"Nat Genet"},{"issue":"12","key":"2812_CR8","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40(12):1461\u20135.","journal-title":"Nat Genet"},{"issue":"12","key":"2812_CR9","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ng.3417","volume":"47","author":"S Buch","year":"2015","unstructured":"Buch S, Stickel F, Tr\u00e9po E, Way M, Herrmann A, Nischalke HD, et al. A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis. Nat Genet. 2015;47(12):1443\u20138.","journal-title":"Nat Genet"},{"issue":"1","key":"2812_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s43066-022-00212-0","volume":"12","author":"SS Youssef","year":"2022","unstructured":"Youssef SS, Abbas EAER, Elfiky AM, Seif S, Nabeel MM, Shousha HI, et al. The impact of polymorphism in PNPLA3 and TM6SF2 genes on the susceptibility and survival of hepatitis C-related hepatocellular carcinoma. Egypt Liver J. 2022;12(1):56.","journal-title":"Egypt Liver J"},{"issue":"3","key":"2812_CR11","first-page":"326","volume":"6","author":"X Zhang","year":"2018","unstructured":"Zhang X, Liu S, Dong Q, Xin Y, Xuan S. The genetics of clinical liver diseases: insight into the TM6SF2 E167K variant. J Clin Transl Hepatol. 2018;6(3):326.","journal-title":"J Clin Transl Hepatol"},{"issue":"8","key":"2812_CR12","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1136\/gutjnl-2020-321299","volume":"69","author":"J Neuberger","year":"2020","unstructured":"Neuberger J, Patel J, Caldwell H, Davies S, Hebditch V, Hollywood C, et al. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut. 2020;69(8):1382\u2013403.","journal-title":"Gut"},{"issue":"105","key":"2812_CR13","first-page":"263","volume":"19","author":"I Labgaa","year":"2015","unstructured":"Labgaa I, Villanueva A. Liquid biopsy in liver cancer. Discov Med. 2015;19(105):263\u201373.","journal-title":"Discov Med"},{"issue":"11","key":"2812_CR14","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1136\/gutjnl-2019-320282","volume":"69","author":"J von Felden","year":"2020","unstructured":"von Felden J, Garcia-Lezana T, Schulze K, Losic B, Villanueva A. Liquid biopsy in the clinical management of hepatocellular carcinoma. Gut. 2020;69(11):2025\u201334.","journal-title":"Gut"},{"key":"2812_CR15","doi-asserted-by":"crossref","unstructured":"Labgaa I, Craig AJ, Villanueva A. Diagnostic and prognostic performance of liquid biopsy in hepatocellular carcinoma. Liquid biopsy in cancer patients: the hand lens for tumor evolution. 2017. pp. 125\u201335.","DOI":"10.1007\/978-3-319-55661-1_14"},{"issue":"1","key":"2812_CR16","first-page":"67","volume":"3","author":"GD Sorenson","year":"1994","unstructured":"Sorenson GD, Pribish DM, Valone FH, Memoli VA, Bzik DJ, Yao S-L. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol Biomarkers Prevent. 1994;3(1):67\u201371.","journal-title":"Cancer Epidemiol Biomarkers Prevent"},{"issue":"1","key":"2812_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.20892\/j.issn.2095-3941.2018.0055","volume":"16","author":"D Qin","year":"2019","unstructured":"Qin D. Next-generation sequencing and its clinical application. Cancer Biol Med. 2019;16(1):4.","journal-title":"Cancer Biol Med"},{"issue":"6","key":"2812_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/CCO.0b013e328359554e","volume":"24","author":"C Desmedt","year":"2012","unstructured":"Desmedt C, Voet T, Sotiriou C, Campbell PJ. Next-generation sequencing in breast cancer: first take home messages. Curr Opin Oncol. 2012;24(6):597\u2013604.","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"2812_CR19","doi-asserted-by":"publisher","first-page":"10424","DOI":"10.1038\/s41598-023-37409-1","volume":"13","author":"EM Jongbloed","year":"2023","unstructured":"Jongbloed EM, Jansen MP, de Weerd V, Helmijr JA, Beaufort CM, Reinders MJ, et al. Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels. Sci Rep. 2023;13(1):10424.","journal-title":"Sci Rep"},{"key":"2812_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-6173-4","volume":"19","author":"S Tang","year":"2019","unstructured":"Tang S, Zhang J, Mei T-T, Guo H-Q, Wei X-H, Zhang W-Y, et al. Association of TM6SF2 rs58542926 T\/C gene polymorphism with hepatocellular carcinoma: a meta-analysis. BMC Cancer. 2019;19:1\u20139.","journal-title":"BMC Cancer"},{"key":"2812_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvr.2023.200256","volume":"15","author":"AM Fteah","year":"2023","unstructured":"Fteah AM, Rahim AA, AbdelHady AA, Shawky H, Elrefaiy MA, Aly DM. Association of PNPLA3 (rs738409) & TM6SF2 (rs58542926) and ATG16L1 (rs2241880) genetic variants with susceptibility to hepatocellular carcinoma in a group of Egyptian patients with HCV-induced liver cirrhosis. Tumour Virus Res. 2023;15: 200256.","journal-title":"Tumour Virus Res"},{"issue":"3","key":"2812_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.5114\/ceh.2022.119265","volume":"8","author":"G Raia","year":"2022","unstructured":"Raia G, Abdelsameea E, Taie DT, Elshaarawy O, Bayomy N, Mostafa R, et al. The TM6SF2 variant as a risk factor for hepatocellular carcinoma development in chronic liver disease patients. Clin Exp Hepatol. 2022;8(3):211\u20138.","journal-title":"Clin Exp Hepatol"},{"issue":"1","key":"2812_CR23","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1038\/s41598-017-04991-0","volume":"7","author":"B Donati","year":"2017","unstructured":"Donati B, Dongiovanni P, Romeo S, Meroni M, McCain M, Miele L, et al. MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals. Sci Rep. 2017;7(1):4492.","journal-title":"Sci Rep"},{"issue":"3","key":"2812_CR24","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/hep4.1822","volume":"6","author":"F Luo","year":"2022","unstructured":"Luo F, Oldoni F, Das A. TM6SF2: a novel genetic player in nonalcoholic fatty liver and cardiovascular disease. Hepatol Commun. 2022;6(3):448\u201360.","journal-title":"Hepatol Commun"},{"issue":"1","key":"2812_CR25","first-page":"27","volume":"7","author":"S Du","year":"2019","unstructured":"Du S, Liao S, Liu S, Xin Y. TM6SF2 E167K variant overexpression promotes expression of inflammatory cytokines in the HCC cell line HEPA 1\u20136. J Clin Transl Hepatol. 2019;7(1):27.","journal-title":"J Clin Transl Hepatol"},{"issue":"10","key":"2812_CR26","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41395-018-0041-8","volume":"113","author":"F Stickel","year":"2018","unstructured":"Stickel F, Buch S, Nischalke HD, Weiss KH, Gotthardt D, Fischer J, et al. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis. Off J Am Coll Gastroenterol ACG. 2018;113(10):1475\u201383.","journal-title":"Off J Am Coll Gastroenterol ACG."},{"key":"2812_CR27","doi-asserted-by":"publisher","first-page":"1026901","DOI":"10.3389\/fendo.2022.1026901","volume":"13","author":"X-Y Li","year":"2022","unstructured":"Li X-Y, Liu Z, Li L, Wang H-J, Wang H. TM6SF2 rs58542926 is related to hepatic steatosis, fibrosis and serum lipids both in adults and children: a meta-analysis. Front Endocrinol. 2022;13:1026901.","journal-title":"Front Endocrinol"},{"issue":"8","key":"2812_CR28","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1053\/j.gastro.2016.01.037","volume":"150","author":"QM Anstee","year":"2016","unstructured":"Anstee QM, Seth D, Day CP. Genetic factors that affect risk of alcoholic and nonalcoholic fatty liver disease. Gastroenterology. 2016;150(8):1728-44.e7.","journal-title":"Gastroenterology"},{"issue":"4","key":"2812_CR29","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s12072-021-10200-y","volume":"15","author":"R Paternostro","year":"2021","unstructured":"Paternostro R, Staufer K, Traussnigg S, St\u00e4ttermayer A-F, Halilbasic E, Keritam O, et al. Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease. Hep Intl. 2021;15(4):922\u201333.","journal-title":"Hep Intl"},{"issue":"1","key":"2812_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1194\/jlr.P067454","volume":"58","author":"M Krawczyk","year":"2017","unstructured":"Krawczyk M, Rau M, Schattenberg JM, Bantel H, Pathil A, Demir M, et al. Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study1. J Lipid Res. 2017;58(1):247\u201355.","journal-title":"J Lipid Res"},{"issue":"1","key":"2812_CR31","doi-asserted-by":"publisher","first-page":"9273","DOI":"10.1038\/s41598-017-09548-9","volume":"7","author":"Z Liu","year":"2017","unstructured":"Liu Z, Que S, Zhou L, Zheng S, Romeo S, Mardinoglu A, et al. The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis. Sci Rep. 2017;7(1):9273.","journal-title":"Sci Rep"},{"key":"2812_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-021-01654-3","volume":"21","author":"AIN Oliveira","year":"2021","unstructured":"Oliveira AIN, Malta FM, Zitelli PMY, Salles APM, Gomes-Gouvea MS, Nastri ACS, et al. The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C. BMC Gastroenterol. 2021;21:1\u201310.","journal-title":"BMC Gastroenterol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02812-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02812-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02812-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T10:05:26Z","timestamp":1749722726000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02812-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2812"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02812-9","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"26 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Medical Research Ethics Committee at the National Research Centre, Egypt has approved the present study and the informed consent.The name of the Approval Committee that approved the study: \u201cThe Medical Research Ethics Committee\u201d.Written informed consent was obtained from the parents of the patients according to the guidelines of \u201cThe Medical Research Ethics Committee\u201d at the National Research Centre (NRC) (approval no. 022052023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Participants or legal guardians have consented for the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1071"}}